Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

IMMULITE Calcitonin Control Module (IMMULITE Recalled by Siemens Healthcare Diagnostics, Inc. Due to A typographical error regarding the expiration date was...

Date: October 20, 2014
Company: Siemens Healthcare Diagnostics, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Siemens Healthcare Diagnostics, Inc. directly.

Affected Products

IMMULITE Calcitonin Control Module (IMMULITE, IMMULITE 1000, IMMULITE 2000, IMMULITE 2000 XPi) For in vitro diagnostic use with IMMULITE¿ Systems Analyzers  for the quantitative measurement of calcitonin (thyrocalcitonin) in human serum or heparinized plasma, as an aid in the diagnosis and treatment of diseases involving the thyroid and parathyroid glands, including carcinoma and hyperparathyroidism.

Quantity: 2212 units (92 units domestically & 2120 units internationally)

Why Was This Recalled?

A typographical error regarding the expiration date was identified in the control module instructions for use.

Where Was This Sold?

This product was distributed to 9 states: CA, FL, KY, MA, MN, NY, PA, UT, VA

Affected (9 states)Not affected

About Siemens Healthcare Diagnostics, Inc.

Siemens Healthcare Diagnostics, Inc. has 452 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report